Risk prediction for clonal cytopenia: multicenter real-world evidence
Key Points
A 3-parameter CCRS model was devised specifically for patients diagnosed with clonal cytopenia.
diagnosis
What have we learned about TP53-mutated acute myeloid leukemia?
Abstract
Manuel Espinoza Gutarra, MD
Espinoza Gutarra, Manuel
Assistant Professor of Medicine
University of Alabama Birmingham
Kah Poh (Melissa) Loh, MBBCh BAO, MS, FACCC
Loh, Kah Poh
Assistant Professor of Medicine
University of Rochester
Online Profile:
Mariam Nawas, MD
Nawas, Mariam
Assistant Professor of Medicine
University of Chicago
Michael Drazer, MD, PhD
Drazer, Michael
Assistant Professor of Medicine
University of Chicago
Michael Drazer, MD, PhD, is a hematologist/oncologist and geneticist specializing in the care of people with blood disorders, blood cancers, hereditary blood disorders, and hereditary cancer syndromes.
Learn about PNH (Paroxysmal Nocturnal Hemoglobinuria)
Caner Saygin, MD
Saygin, Caner
Assistant Professor of Medicine
University of Chicago
Yael Kusne, MD PhD
Kusne, Yael
Assistant Professor of Medicine
Mayo Clinic, Phoenix, AZ